Prebet T, Fenaux P, Vey N; Groupe Francophone des Myelodysplasies (GFM).

Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system.

Haematologica. 2016 Oct;101(10):e427-e428. No abstract available.